MARKET SCAMS

[thepennyking]

Class Action Lawsuit Against Medical Staffing Network Holdings, Inc.
BALTIMORE, MD -- (MARKET WIRE) -- 02/20/2004 -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action has been commenced on behalf of shareholders who purchased the common stock of Medical Staffing Network Holdings, Inc. (NYSE: MRN) traceable to Medical Staffing's Registration/Statement/Prospectus used in connection with its April 17, 2002 Initial Public Offering.

The case is pending in the United States District Court for the Southern District of Florida against defendant Medical Staffing and certain of its officers and directors.

The action charges that defendants violated federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period which statements had the effect of artificially inflating the market price of the Company's securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you are a member of the Class, you may move the court no later than April 19, 2004 to serve as a lead plaintiff for the Class. In order to serve as a lead plaintiff, you must meet certain legal requirements. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice.

If you acquired shares of Medical Staffing Network Holdings, Inc. traceable to its Registration Statement/Prospectus used in connection with its April 17, 2002 Initial Public Offering and want to discuss your legal rights, you may e-mail or call Law Offices Of Charles J. Piven, P.A. who will, without obligation or cost to you, attempt to answer your questions. Law Offices Of Charles J. Piven has been involved in securities litigation for over ten years. You may contact Law Offices Of Charles J. Piven, P.A. at The World Trade Center-Baltimore, 401 East Pratt Street, Suite 2525, Baltimore, Maryland 21202, by email at [e-mail] or by calling 410/986-0036.

http://www.marketwire.com/mw/release_html_b1?release_id=63399